DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling

DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling

Hua Zhou,1,* Xiaodie Mu,2,* Huiyue Hu,1,* Shuya Zhao,1 Nan Hu,3 Min Yang,1,* Jingting Jiang4– 6,* 1Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, People’s Republic of China; 2Department of...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhou H, Mu X, Hu H, Zhao S, Hu N, Yang M, Jiang J
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Drug Design, Development and Therapy
Subjects:
bile acid
diabetic kidney disease
farnesoid X receptor
gut microbiota
Takeda G protein-coupled receptor 5
Online Access:https://www.dovepress.com/dhlca-alleviates-diabetic-kidney-disease-via-tgr5fxr-activation-and-gu-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/dhlca-alleviates-diabetic-kidney-disease-via-tgr5fxr-activation-and-gu-peer-reviewed-fulltext-article-DDDT

Similar Items